Mouse monoclonal [JDC-10] Anti-Human IgG Fc (HRP) (ab99759)
Key features and details
- Mouse monoclonal [JDC-10] Anti-Human IgG Fc (HRP)
- Conjugation: HRP
- Host species: Mouse
- Isotype: IgG1
- Suitable for: ELISA, WB, IHC-Fr, Dot blot, ICC
Related conjugates and formulations
製品の概要
-
製品名
Mouse monoclonal [JDC-10] Anti-Human IgG Fc (HRP)
IgG 二次抗体 製品一覧 -
由来種
Mouse -
ターゲット生物種
Human -
特異性
ab99759 reacts with the Fc portion of the heavy chain of all subclasses of Human IgG as demonstrated by ELISA; may also react with IgG from other species. -
アプリケーション
適用あり: ELISA, WB, IHC-Fr, Dot blot, ICCmore details -
標識
HRP
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 7.40
Constituents: 50% Glycerol, 50% PBS -
Concentration information loading...
-
精製度
Protein G purified -
ポリ/モノ
モノクローナル -
クローン名
JDC-10 -
アイソタイプ
IgG1 -
軽鎖の種類
kappa -
研究分野
関連製品
-
Alternative Versions
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab99759の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ELISA |
1/1000 - 1/2000.
|
|
WB |
Use at an assay dependent dilution.
|
|
IHC-Fr |
Use at an assay dependent dilution.
|
|
Dot blot |
Use at an assay dependent dilution.
|
|
ICC |
Use at an assay dependent dilution.
|
特記事項 |
---|
ELISA
1/1000 - 1/2000. |
WB
Use at an assay dependent dilution. |
IHC-Fr
Use at an assay dependent dilution. |
Dot blot
Use at an assay dependent dilution. |
ICC
Use at an assay dependent dilution. |
画像
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (10)
ab99759 は 10 報の論文で使用されています。
- Timilsina SS et al. Rapid quantitation of SARS-CoV-2 antibodies in clinical samples with an electrochemical sensor. Biosens Bioelectron 223:115037 (2023). PubMed: 36584477
- Jensen C et al. Autoreactivity against Denatured Type III Collagen Is Significantly Decreased in Serum from Patients with Cancer Compared to Healthy Controls. Int J Mol Sci 24:N/A (2023). PubMed: 37108227
- Yuan M et al. An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant. One Health Adv 1:12 (2023). PubMed: 37521533
- Bi J et al. A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus. Front Microbiol 13:927122 (2022). PubMed: 35756049
- Staudacher AH et al. The RNA-binding protein La/SSB associates with radiation-induced DNA double-strand breaks in lung cancer cell lines. Cancer Rep (Hoboken) 5:e1543 (2022). PubMed: 34636174
- Li T et al. Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants. Nat Commun 12:6304 (2021). PubMed: 34728625
- Alrashoudi AA et al. Fabrication of a Lateral Flow Assay for Rapid In-Field Detection of COVID-19 Antibodies Using Additive Manufacturing Printing Technologies. Int J Bioprint 7:399 (2021). PubMed: 34805593
- Zamora-Gálvez A et al. Photoluminescent lateral flow based on non-radiative energy transfer for protein detection in human serum. Biosens Bioelectron 100:208-213 (2018). PubMed: 28915385
- Horie T et al. Identification of OmpA-Like Protein of Tannerella forsythia as an O-Linked Glycoprotein and Its Binding Capability to Lectins. PLoS One 11:e0163974 (2016). ELISA . PubMed: 27711121
- Akiyama S et al. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol 19:653-60 (2015). WB . PubMed: 25412738